BACILLUS COAGULANS MARKET ANALYSIS

The Bacillus Coagulans Market is estimated to be valued at USD 126.9 Mn in 2024 and is expected to reach USD 221.8 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031.

Bacillus coagulans is a bacteria utilized as a probiotic. The bacteria’s ability to withstand harsh acidic environments has led to its adoption in probiotics, which specifically target the human digestive system. It is useful in alleviating stomach ailments, constipation, flatulence, abdominal pain, and irritable bowel syndrome. Due to the bacteria’s efficacious properties, it finds application in both human and animal nutrition. Other beneficial properties include improved immunity, prevention of respiratory disorders, and anti-carcinogenic agents.

Drivers

Bacillus coagulans market is witnessing growing demand in the cosmetic industry, owing to the immense benefits offered in managing acne and skin problems. New formulations including Bacillus coagulans are being launched by cosmetics providers for anti-aging effects. These products include face masks, lotion, scrub, gel, creams, and cleansers. Cosmetics product manufacturers are also focusing on developing cosmeceutical ingredients including bacillus coagulans to be used in various cosmetic products including cream, lotion, powder, and others. Bacillus coagulans are also gaining popularity in treating and managing symptoms of atopic dermatitis and eczema. Its incorporation in cosmetic products including anti-acne face wash and moisturizing cream is also on a rise. Owing to its biological activity and protection of skin, bacillus coagulans are widely used in personal care products.

The emerging economies of ASEAN, China, and India are expected to be the key markets for bacillus coagulans, as these are the major consumers of functional food and beverages. Moreover, increasing geriatric population in these economies is one of the major factors driving growth of the market.

Among regions, Asia Pacific held the largest revenue share of 55.7% in the global bacillus coagulans market in 2020.  The region is also projected to be the fastest growing with a CAGR of over the forecast period. This can be attributed to rising healthcare spending by the populace in the region. to the in South East Asia, the healthcare spending in ASEAN countries was estimated to be around US$ 182 billion, in 2019.

Figure 1. Global Bacillus Coagulans Market Revenue Share (%), By Region, 2024

To learn more about this report, request sample copy

Market Restraints

Side-effects of Bacillus coagulans is very mild but carelessness in dosage can result in intestinal gas and bloating. There is an ongoing debate on potential risk and side-effects of bacillus coagulans because it is not naturally present in the digestive system. Various strains of bacillus coagulans have been identified that may not be safe to use as probiotics. While bacillus coagulans may offer several benefits as compared to other probiotics, the research done on these probiotics is still limited. There is also a concern that spores produced by bacillus coagulans can move out of the digestive tract and reach other parts. Hence, it is not recommended for people with immunocompromised conditions, or the person using a catheter as it may lead to bacterial infection.

Market Trends

Wellness and health continue to be at the forefront of new product development strategies with new dairy-free probiotic foods hitting the market each year. Bacillus coagulans are emerging as the main ingredient in the majority of dairy-free food. There has been an increased in demand for non-dairy probiotics, owing to the rise in the vegetarian and vegan desire for low milk cholesterol and increased lactose intolerance. Reported safe by the US food and drug administration and European Food Safety Authority , bacillus coagulans are largely added in dairy-free probiotic supplements and functional food products. The high stability of bacillus coagulans through heating and processing is leading to the growing demand for heat-treated food products. Most of the products used in the food industry that can be produced by Bacillus coagulans are gaining popularity due to the alternative to other harmful chemical sources such as guar gum, artificial sweeteners, etc.

Figure 2. Global Bacillus Coagulans Market Revenue Share (%), By Application, 2024

To learn more about this report, request sample copy

On the basis of application, in 2020, functional food segment held largest revenue share of 36.9% in the global bacillus coagulans market. The segment is expected to be the largest and the fastest growing over the forecast period. Functional food such as breakfast cereals, gels, bars, and gummies are popular products infused with bacillus coagulans. Dairy products, sports beverages, and baked goods are also popular applications of bacillus coagulans. The bacteria in bacillus coagulans is highly stable at high temperatures and is viable during high temperature processes such as baking.

Global Bacillus Coagulans Market - Impact of Coronavirus (COVID-19) Pandemic

In recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global bacillus coagulans market is no different, and this factor is expected to have a significantly negative impact on the revenue growth of this industry. The ongoing COVID-19 pandemic has changed the eating and drinking habits of people. People have become more conscious about the food they have been consuming on a day-to-day basis. Moreover, there is an increasing demand for pure and natural ingredients in probiotic products which has led the key players in the market to expand their product offerings with an extensive range of authentic fruit-based probiotic products.

Key Developments:

• In 2024, Cambridge Commodities launched ActiBio BS, a new probiotic solution containing Bacillus subtilis, as an alternative to its original ActiBio probiotic which uses Bacillus coagulans
• In October 2023, NZ’s Gutsi launched a 60-day Gut Reset Kit, hoping to make practitioner-grade supplements more accessible to consumers
• In September 2022, Optibac Probiotics announced the introduction of its first vegan gummy to support gut and immune health among adults. Adult Gummies is a mixed berry all-in-one supplement which contains probiotic strain Bacillus coagulans Unique IS-2, as well as daily doses of vitamin D, zinc, and calcium.
• In 2022, Kerry Taste & Nutrition launched a liquid version of its BC30 (Bacillus coagulans GBI-30, 6086) probiotic that can be used in plant-based and liquid milk products. It is the first commercially available liquid BC30, which is a spore-forming probiotic ingredient that can withstand heat and manufacturing processes.

*Definition: Bacillus coagulans is a type of beneficial bacteria commonly used as a probiotic supplement. It is a lactic acid-producing bacterium that is known for its ability to survive harsh conditions, such as high temperatures and acidic environments, making it particularly resilient and effective for use in various products. Bacillus coagulans is often used to promote gut health, aid digestion, boost the immune system, and support overall well-being. It is commonly found in fermented foods and dietary supplements.

Competitive Section

Major players operating in the global bacillus coagulans market include Sanzyme, Unique Biotech Limited (UBL), Zytex, Bioflex, Fengchen Group Co., Ltd, RAJVI Enterprise, Vakya life sciences, Sabinsa Corporation, Ganeden, UAS Laboratories, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., and Nebraska Culture.

Market Segmentation:

• Application Insights (Revenue, USD Mn, 2019 - 2031)
  • Non-Dairy
  • Dairy
  • Cereal
  • Infant Nutrition
  • Others
• End-users Insights (Revenue, USD Mn, 2019 - 2031)
  • Cosmeceutical Manufacturers
  • Food and Beverages
  • Nutraceutical
  • Others
• Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Key Players Insights
  • Sanzyme
  • Unique Biotech Limited (UBL)
  • Zytex
  • Bioflex
  • Fengchen Group Co., Ltd
  • RAJVI Enterprise
  • Vakya life sciences
  • Sabinsa Corporation
  • Ganeden
  • UAS Laboratories
  • Mitsubishi Chemical Foods Corporation
  • Mystical Biotech Pvt. Ltd.
  • Aumgene Biosciences
  • Unique Biotech Ltd.
  • Nebraska Culture